Writing Intervention With Adolescents and Young Adults With Cancer
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- В протоколе указаны: Writing, Interview.
- Кому может быть актуально
- Состояния в реестре: Cancer Patients, Communication Research. Базовые параметры: 15 лет — 25 лет · Все.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- США
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Официальное название
ChronCan (Chronicling Cancer): Piloting a Novel Writing Intervention With Adolescents and Young Adults With Cancer
Обзор
Young people with cancer have difficult experiences and writing exercises may help improve their well-being. However, very few studies have examined how a creative writing activity might be useful for young people with cancer. In this pilot study, researchers at St. Jude Children's Research Hospital hope to explore whether teenagers and young adults with cancer want to participate in a writing exercise and whether they find it to be valuable. Primary Objective To assess the feasibility and acceptability of a writing-based narrative medicine intervention for adolescent and young adult patients with cancer.
Подробное описание
Participants will be given the opportunity to write about their experiences with cancer, with support and guidance from an expert writer. Participants will meet briefly with the expert at the start of the exercise (15-30 minutes), and they can choose to meet 1-3 additional times with the expert over the next 2 months to receive further support if they wish.
After completing the writing exercise, participants will do an informal interview to share their thoughts about whether the experience of writing felt helpful or not. The post-intervention interview will occur at around 2 months after enrollment, +/- 1 month. Patients may participate in a second informal semi-structured interview 6 to 12 months after completing the first interview. Additionally, bereaved parents may participate in an informal interview on study.
Вмешательства
- Поведенческое Writing
Participants will be asked to write about their experiences with cancer, guided by several specific open-ended writing prompts to spark ideas. - Поведенческое Interview
Following completion of the writing exercise, participants will reflect on their experiences with the writing intervention in a semi-structured private interview with a member of the research team.
Первичные конечные точки
- Number of touchpoints that participants have with the narrative medicine expert/guide [Срок оценки: During the narrative exercise, up to 2 months after enrollment]
- Number of participants who complete the writing exercise [Срок оценки: During the narrative exercise, up to 2 months after enrollment]
- Intervention acceptability [Срок оценки: Post-intervention interview will occur after the narrative exercise is completed at around 2 months after enrollment, +/- 1 month]
Критерии участия
Критерии включения
- Aged 15-25
- Currently receiving cancer-directed therapy
- Active patient at St. Jude Children's Research Hospital
- Parent of a ChronCan participant who has passed away
Критерии исключения
- Does not meet the inclusion criteria
- If the parents have not responded or not interviewed till July 31, 2027.
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Нет
Дизайн исследования
- Распределение
- Не применимо
- Модель
- Одна группа
- Маскирование
- Открытое
- Основная цель
- Другое
Центры проведения
США · 1 центр
- St. Jude Children's Research Hospital — Memphis
Идентификаторы
NCT: NCT05975333 · ChronCan · NCI-2023-06074